ALDMS — DIAGNOSTIC MEDICAL SYSTEMS SA Income Statement
0.000.00%
- €22.31m
- €37.66m
- €46.07m
- 44
- 62
- 85
- 73
Annual income statement for DIAGNOSTIC MEDICAL SYSTEMS SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.2 | 37 | 35.3 | 42.2 | 46.1 |
Cost of Revenue | |||||
Gross Profit | 12.6 | 13.9 | 13.8 | 15.8 | 18.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.8 | 40.6 | 41.1 | 44.4 | 46.4 |
Operating Profit | -4.58 | -3.6 | -5.88 | -2.27 | -0.346 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.54 | -3.95 | -6.64 | -9.83 | -2.61 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.53 | -3.95 | -6.66 | -9.84 | -2.82 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.24 | -3.88 | -6.82 | -4.95 | -2.88 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.24 | -3.88 | -6.82 | -4.95 | -2.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.284 | -0.037 | -0.326 | -0.559 | -0.177 |
Dividends per Share |